ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
NCT ID: NCT06526546
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
356 participants
OBSERVATIONAL
2024-10-31
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ADVENT Post Approval Study
NCT06431815
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
NCT04612244
Atrioventricular Nodal Ablation Versus Pulmonary Vein Isolation - Patient Centred Decisions
NCT07059208
A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation
NCT05443594
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
NCT03355456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who were enrolled, randomized and treated for paroxysmal atrial fibrillation, classified as Modified Intention-to-Treat subjects, and completed the 12-Month Follow-Up in the FARAPULSE ADVENT Trial (CIP CS0934; NCT04612244).
* Subjects or legally authorized representatives who are willing and capable of providing informed consent.
* Subjects who are willing to comply with the protocol requirements.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vivek Reddy
Role: PRINCIPAL_INVESTIGATOR
MOUNT SINAI HOSPITAL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grandview Medical Center
Birmingham, Alabama, United States
Banner University Medical Center Phoenix
Phoenix, Arizona, United States
Mills Peninsula Health Services
Burlingame, California, United States
Scripps Memorial Hospital
La Jolla, California, United States
University of California, San Francisco
San Francisco, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Emory University Hospital
Atlanta, Georgia, United States
St. Lukes Idaho Cardiology Associates
Boise, Idaho, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Massachusetts General Hospital (MGH)
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
St. Luke's Hospital of Kansas City
Kansas City, Missouri, United States
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Mount Sinai, Icahn School of Medicine
New York, New York, United States
Northwell Health
New York, New York, United States
Providence St. Vincent Medical Center
Portland, Oregon, United States
Doylestown Hospital
Doylestown, Pennsylvania, United States
Presbyterian University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
Pinnacle Health at Harrisburg Hospital
Wormleysburg, Pennsylvania, United States
Trident Medical Center
Charleston, South Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
St. Thomas Research Institute, LLC
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Texas Cardiac Arrhythmia Research
Austin, Texas, United States
Virginia Commonwealth University Health System
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PF116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.